Business Context and Reporting Period
This Form 8-K is a current report filed by AmerisourceBergen Corporation (now Cencora, Inc.) on September 22, 2022. The filing discloses corporate governance changes, specifically the election of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on personnel and governance matters.
Material Changes
The Board of Directors elected Lorence H. Kim, M.D., to serve as a director, effective October 1, 2022. Consequently, the Board size increased from ten to eleven members. Dr. Kim will serve on the Finance Committee and is considered an independent director.
Guidance, Outlook, and Management Commentary
There is no financial guidance, outlook, or management commentary regarding business performance in this filing. The document details Dr. Kim's background, including his roles as a Venture Partner at Third Rock Ventures, former CFO of Moderna, Inc., and former Managing Director at Goldman, Sachs & Co. His compensation includes an annual cash retainer of $100,000 and an annual equity award valued at $200,000 on the grant date. No related party transactions requiring disclosure were identified.
Investor Verification Checklist
- Confirm the effective date of Dr. Kim's board service (October 1, 2022).
- Verify the updated Board composition (11 members).
- Review the attached news release (Exhibit 99.1) for additional context on the election.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.